Merck
  • Home
  • Search Results
  • Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.

Targeting the spliceosome through RBM39 degradation results in exceptional responses in high-risk neuroblastoma models.

Science advances (2021-11-18)
Shivendra Singh, Waise Quarni, Maria Goralski, Shibiao Wan, Hongjian Jin, Lee-Ann Van de Velde, Jie Fang, Qiong Wu, Ahmed Abu-Zaid, Tingting Wang, Ravi Singh, David Craft, Yiping Fan, Thomas Confer, Melissa Johnson, Walter J Akers, Ruoning Wang, Peter J Murray, Paul G Thomas, Deepak Nijhawan, Andrew M Davidoff, Jun Yang
PMID34788094
ABSTRACT

[Figure: see text].

MATERIALS
Product Number
Brand
Product Description
09-774
Sigma-Aldrich
Anti-EED Antibody, from rabbit
F2442
Sigma-Aldrich
Fetal Bovine Serum, USA origin, sterile-filtered, suitable for cell culture, suitable for hybridoma
D9307
Sigma-Aldrich
JumpStart™ Taq DNA Polymerase, with MgCl2
A5441
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid
MP0035
Sigma-Aldrich
LookOut® Mycoplasma PCR Detection Kit, Optimized for use with JumpStart™ Taq DNA Polymerase, D9307.
F1804
Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)